El Salvador vs Uruguay: HIV/AIDS deaths averted by antiretroviral therapy
El Salvador
521.19 deaths
in 2024
Uruguay
516 deaths
in 2022
El Salvador rank
90th
Uruguay rank
91st
HIV/AIDS deaths averted by antiretroviral therapy over time
- El Salvador
- Uruguay
How they compare
El Salvador currently reports 521.19 deaths against 516 deaths in Uruguay, a difference of 5.19 deaths.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was Uruguay ahead.
El Salvador ranks 90th and Uruguay ranks 91st of 157 countries.
Across the 4 decades both report, El Salvador averaged higher in 3 and Uruguay in 1.
Head to head by decade
| Decade | El Salvador | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 25 deaths | 25 deaths | Uruguay |
| 2000s | 374.61 deaths | 166.5 deaths | 208.11 deaths | El Salvador |
| 2010s | 792.19 deaths | 364 deaths | 428.19 deaths | El Salvador |
| 2020s | 578.45 deaths | 487 deaths | 91.45 deaths | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, El Salvador or Uruguay?
- El Salvador, at 521.19 deaths against 516 deaths in Uruguay as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between El Salvador and Uruguay?
- 5.19 deaths, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Uruguay?
- 33 years are reported by both, from 1990 to 2022.
- How do El Salvador and Uruguay rank globally for hiv/aids deaths averted by antiretroviral therapy?
- El Salvador ranks 90th and Uruguay ranks 91st of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.